In Conversation

“ We do not have the strength to compete with traditional players, so being digitally disruptive is our key asset ”
“ Cell culture technology is the core for bio-manufacturing, not only recombinant proteins but any biologicals, including vaccines as well as gene and cell therapies! ”
“ Our goal was to revolutionize the way chronic illness is managed and create a modern solution using today’s technology ”
“ Looking at our portfolio mix and our operations, we can see that the biotech boom in China is really driving demand for new solutions ”
“ Through close collaboration with KOLs and medical doctors, we will continue to explore the different ways to utilize cell treatment therapy ”
“ AI is the future of the industry that has all the potential to transform and combat the complex drug discovery process. ”
“ We came up with the concept of digitizing the best treatment practices and putting them online to reach more patients ”
“ The most important factor in Taiwan’s biotech environment is talent ”
“ Whether Taiwan’s biomedical industry can be robust will depend on the kinds of technologies we can build ”
“ We are on the right track in terms of collaborating with the industry, and we even have more trials than patients! ”
“ Paradoxically, I believe you can find the most opportunities when the environment is complicated or difficult. This is why I decided to start a biotech company… ”
“ Our first investment was into PharmaEngine which several years later became a success story. Additionally, we invested in ten other corporations including Mycenax Biotech, Brim Biotechnology,… ”
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here